Literature DB >> 30374627

Medication Decision-making in Osteoporosis: Can We Explain Why Patients Do Not Take Their Osteoporosis Medications?

Stuart Silverman1,2, Deborah T Gold3.   

Abstract

Patients at high risk of fracture often do not take medication for osteoporosis. Recent literature may give us some insights into why patients at high risk of fracture do not take medications for osteoporosis.

Entities:  

Keywords:  Adherence; Medication decision-making; Osteoporosis

Mesh：

Substances：

Year:  2018        PMID： 30374627     DOI： 10.1007/s11914-018-0494-0

Source DB:  PubMed          Journal:  Curr Osteoporos Rep        ISSN： 1544-1873            Impact factor:   5.096


  22 in total

Review 1.  Optimistic biases about personal risks.

Authors:  N D Weinstein
Journal:  Science       Date:  1989-12-08       Impact factor: 47.728

2.  Quantifying the utility of taking pills for cardiovascular prevention.

Authors:  Robert Hutchins; Anthony J Viera; Stacey L Sheridan; Michael P Pignone
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2015-02-03

3.  Patient information recall in a rheumatology clinic.

Authors:  J L Anderson; S Dodman; M Kopelman; A Fleming
Journal:  Rheumatol Rehabil       Date:  1979-02

4.  Older men's explanatory model for osteoporosis.

Authors:  Samantha L Solimeo; Thomas J Weber; Deborah T Gold
Journal:  Gerontologist       Date:  2011-02-10

5.  An evaluation of patient preferences for osteoporosis medication attributes: results from the PREFER-US study.

Authors:  Thomas W Weiss; Deborah T Gold; Stuart L Silverman; Colleen A McHorney
Journal:  Curr Med Res Opin       Date:  2006-05       Impact factor: 2.580

6.  Comparison of risk perceptions and beliefs across common chronic diseases.

Authors:  Catharine Wang; Suzanne M O'Neill; Nan Rothrock; Robert Gramling; Ananda Sen; Louise S Acheson; Wendy S Rubinstein; Donald E Nease; Mack T Ruffin
Journal:  Prev Med       Date:  2008-11-25       Impact factor: 4.018

7.  Patient weighting of osteoporosis medication attributes across racial and ethnic groups: a study of osteoporosis medication preferences using conjoint analysis.

Authors:  S Silverman; A Calderon; K Kaw; T B Childers; B A Stafford; W Brynildsen; A Focil; M Koenig; D T Gold
Journal:  Osteoporos Int       Date:  2012-12-18       Impact factor: 4.507

8.  Primary non-adherence to bisphosphonates in an integrated healthcare setting.

Authors:  K Reynolds; P Muntner; T C Cheetham; T N Harrison; D E Morisky; S Silverman; D T Gold; S S Vansomphone; R Wei; C D O'Malley
Journal:  Osteoporos Int       Date:  2013-04-18       Impact factor: 4.507

Review 9.  Compliance and persistence with osteoporosis medications: a critical review of the literature.

Authors:  Stuart Silverman; Deborah T Gold
Journal:  Rev Endocr Metab Disord       Date:  2010-12       Impact factor: 6.514

10.  Encounter Decision Aid vs. Clinical Decision Support or Usual Care to Support Patient-Centered Treatment Decisions in Osteoporosis: The Osteoporosis Choice Randomized Trial II.

Authors:  Annie LeBlanc; Amy T Wang; Kirk Wyatt; Megan E Branda; Nilay D Shah; Holly Van Houten; Laurie Pencille; Robert Wermers; Victor M Montori
Journal:  PLoS One       Date:  2015-05-26       Impact factor: 3.240
View more
  1 in total

1.  Effect of teriparatide on quality of life in patients with postmenopausal osteoporosis: a retrospective cohort study.

Authors:  Tiansong Yang; Chuwen Feng; Yuanyuan Qu; Qingyong Wang; Yan Yang; Bo Wang; Zhongren Sun; Shengyong Bao
Journal:  J Int Med Res       Date:  2019-10-10       Impact factor: 1.671
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.